Page last updated: 2024-10-21

3-methylcholanthrene and Lymphopenia

3-methylcholanthrene has been researched along with Lymphopenia in 1 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Lymphopenia: Reduction in the number of lymphocytes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saida, Y1
Watanabe, S1
Tanaka, T1
Baba, J1
Sato, K1
Shoji, S1
Igarashi, N1
Kondo, R1
Okajima, M1
Koshio, J1
Ichikawa, K1
Nozaki, K1
Ishikawa, D1
Koya, T1
Miura, S1
Tanaka, J1
Kagamu, H1
Yoshizawa, H1
Nakata, K1
Narita, I1

Other Studies

1 other study available for 3-methylcholanthrene and Lymphopenia

ArticleYear
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
    Journal of immunology (Baltimore, Md. : 1950), 2015, Jul-15, Volume: 195, Issue:2

    Topics: Adoptive Transfer; Animals; Cisplatin; Cyclophosphamide; Cytotoxins; Deoxycytidine; Drug Resistance;

2015